NICEVIVA
Clinical Disclaimer: This guide summarizes peer-reviewed PubMed literature and does not replace professional medical advice, diagnosis, or pharmacist counseling.
EDITORIAL METHODOLOGY PUBMED · 14,786 STUDIES

NICEVIVA GRADE Evidence Methodology & 14,357-Study PubMed Audit

“Backed by a study” often means a petri-dish or rodent experiment. NICEVIVA separates human randomized controlled trials (RCTs) and meta-analyses from preclinical hype using standardized GRADE methodology.

591
Independent Monographs
Full KO/EN bilingual corpus
14,786
Verified PubMed Trials
Direct PMID links
4 Tiers
GRADE Evidence Tiers
High · Moderate · Low · Very Low
KEY FORMULATION & CLINICAL DIFFERENCE

Cherry-Picked Single Trials vs. Pooled Meta-Analytic Effect Sizes (95% CI)

An underpowered 15-person pilot study cannot establish clinical efficacy. Each NICEVIVA monograph reports the exact count of Meta-Analyses, Systematic Reviews, and RCTs alongside pooled participant counts (n) and quantitative effect sizes.

Step-by-Step Evaluation & Dosing Protocol

STEP 01

NCBI PubMed Ingestion & Retraction Gate

Zero Retracted Publications

Ingests indexed human studies from NCBI PubMed while automatically blocking retracted publications.

STEP 02

Study Design Classification & Quantitative Extraction

Sample Size (n) · Effect Size · 95% CI · p-value

Extracts participant sample sizes, standardized mean differences (SMD), odds/risk ratios, 95% confidence intervals, and p-values.

STEP 03

GRADE Tiering & Balanced Worth/Skip Verdict

Who Benefits vs. Who Should Skip

Presents a balanced two-column clinical verdict: cohorts with proven benefit versus cohorts who should skip or exercise caution.

STEP 04

100% Local Browser Personalization

Privacy-First Client-Side Lens

Your selected GI traits and prescription filters execute strictly in local browser memory without external transmission.

1. How to Interpret GRADE Evidence Levels

High and Moderate GRADE ratings indicate consistent findings across multiple well-powered RCTs and meta-analyses, whereas Low ratings signal preliminary or heterogeneous evidence.

Hierarchy of Clinical Evidence in NICEVIVA Monographs

Study DesignHierarchy TierKey Metrics AuditedInterpretation Caveat
Meta-Analysis & Systematic ReviewTier 1 (Highest)Pooled effect size, 95% CI, heterogeneity (I²)Check quality of underlying trials
Randomized Controlled Trial (RCT)Tier 2 (High)Sample size (n), placebo-adjusted p-valueVerify exact salt form and trial duration
Observational CohortTier 3 (Moderate/Low)Hazard/Odds ratios, confounder adjustmentDemonstrates association, not causation
Preclinical (In Vitro / Animal)Mechanistic OnlyBiochemical pathway explorationCannot be extrapolated directly to human dosing

Related Supplement Monographs (PubMed PMID & GRADE Verified)

Browse All 591 Monographs →

Frequently Asked Questions (FAQ)

Does NICEVIVA accept brand sponsorships or affiliate payments?

Never. NICEVIVA evaluates generic active ingredients and chemical formulations strictly from peer-reviewed PubMed literature with zero commercial bias.

MORE FORMULATION & CLINICAL GUIDES

More Clinical Formulation & Safety Guides

FORMULATION CRITICAL PROTOCOL 01

Chelate vs. Inorganic Salt Bioavailability & GI Tolerability

Identical elemental labels hide vast pharmacokinetic differences. Compare inorganic salts (Magnesium Oxide, Calcium Carbonate) against amino-acid chelates (Bisglycinate, Citrate) for bioavailability and GI comfort.

Read Formulation Guide →
RX SAFETY · 122 INTERACTIONS PROTOCOL 02

Prescription Drug–Supplement Interaction & Contraindication Matrix

Audit 122 documented pharmacokinetic and pharmacodynamic drug-supplement interactions—covering anticoagulants, levothyroxine chelation, metformin B12 depletion, and serotonergic toxicity.

Read Formulation Guide →
CHRONOBIOLOGY TIMING PROTOCOL 03

Chronobiology Dosing Schedule: Morning Fasted vs. Evening Post-Meal

Taking B-complex or CoQ10 at night can disrupt sleep architecture, while taking fat-soluble Vitamin D, Omega-3, or CoQ10 on an empty stomach slashes micellar absorption. Optimize your daily timing.

Read Formulation Guide →
ALOPECIA MONOGRAPH PROTOCOL 04

Alopecia Protocol: Androgenetic DHT vs. Diffuse Ferritin & Keratin

Androgenetic miniaturization (DHT-driven) and diffuse telogen effluvium (ferritin/amino-acid depletion) require distinct interventions. Review RCT evidence for Pumpkin Seed Oil, Medicinal Yeast, and Biotin safety.

Read Formulation Guide →
LIPID CLINICAL AUDIT PROTOCOL 05

Omega-3 Monograph: rTG vs. EE Bioavailability, Oxidation & Dose Thresholds

Evaluate Omega-3 formulations across chemical backbone (rTG vs. Ethyl Ester), EPA:DHA ratios, TOTOX oxidation limits, and clinical dose thresholds for hypertriglyceridemia vs. dry eye.

Read Formulation Guide →